Alyeska Investment Group’s Elevance Health ELV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-39,879
| Closed | -$10.5M | – | 500 |
|
|
2020
Q2 | $10.5M | Sell |
39,879
-786
| -2% | -$207K | 0.16% | 192 |
|
|
2020
Q1 | $9.23M | Buy |
+40,665
| New | +$9.23M | 0.18% | 134 |
|
|
2019
Q3 | – | Sell |
-251,870
| Closed | -$71.1M | – | 395 |
|
|
2019
Q2 | $71.1M | Buy |
251,870
+103,007
| +69% | +$29.1M | 0.92% | 27 |
|
|
2019
Q1 | $42.7M | Sell |
148,863
-91,974
| -38% | -$26.4M | 0.56% | 54 |
|
|
2018
Q4 | $63.3M | Buy |
240,837
+97,122
| +68% | +$25.5M | 0.92% | 22 |
|
|
2018
Q3 | $39.4M | Sell |
143,715
-183,351
| -56% | -$50.2M | 0.43% | 78 |
|
|
2018
Q2 | $77.9M | Sell |
327,066
-44,667
| -12% | -$10.6M | 0.7% | 37 |
|
|
2018
Q1 | $81.7M | Sell |
371,733
-55,378
| -13% | -$12.2M | 0.68% | 46 |
|
|
2017
Q4 | $96.1M | Sell |
427,111
-112,313
| -21% | -$25.3M | 0.76% | 39 |
|
|
2017
Q3 | $102M | Sell |
539,424
-13,077
| -2% | -$2.48M | 0.76% | 32 |
|
|
2017
Q2 | $104M | Buy |
552,501
+200,000
| +57% | +$37.6M | 0.87% | 25 |
|
|
2017
Q1 | $58.3M | Buy |
352,501
+329,735
| +1,448% | +$54.5M | 0.47% | 65 |
|
|
2016
Q4 | $3.27M | Buy |
+22,766
| New | +$3.27M | 0.03% | 351 |
|
|
2016
Q2 | – | Sell |
-169,123
| Closed | -$23.5M | – | 429 |
|
|
2016
Q1 | $23.5M | Buy |
+169,123
| New | +$23.5M | 0.22% | 166 |
|
|
2015
Q2 | – | Sell |
-162,047
| Closed | -$25M | – | 484 |
|
|
2015
Q1 | $25M | Sell |
162,047
-134,801
| -45% | -$20.8M | 0.35% | 106 |
|
|
2014
Q4 | $37.3M | Buy |
296,848
+167,074
| +129% | +$21M | 0.64% | 36 |
|
|
2014
Q3 | $15.5M | Buy |
+129,774
| New | +$15.5M | 0.32% | 112 |
|
|
2014
Q2 | – | Sell |
-219,353
| Closed | -$21.8M | – | 375 |
|
|
2014
Q1 | $21.8M | Buy |
219,353
+54,353
| +33% | +$5.41M | 0.6% | 32 |
|
|
2013
Q4 | $15.2M | Buy |
165,000
+20,000
| +14% | +$1.85M | 0.6% | 37 |
|
|
2013
Q3 | $12.1M | Buy |
145,000
+85,000
| +142% | +$7.11M | 0.5% | 50 |
|
|
2013
Q2 | $4.91M | Buy |
+60,000
| New | +$4.91M | 0.24% | 110 |
|